42 results
424B5
ITCI
Intra-Cellular Therapies Inc
5 Jan 22
Prospectus supplement for primary offering
4:51pm
liability claims; and
our reputation may suffer.
Any of these events could prevent us from achieving or maintaining market acceptance of the affected … for us and their work for another entity, we may lose their services, which may impair our reputation in the industry and delay the development
424B5
ITCI
Intra-Cellular Therapies Inc
3 Jan 22
Prospectus supplement for primary offering
5:30pm
reputation may suffer.
Any of these events could prevent us from achieving or maintaining market acceptance of the affected product or could … for another entity, we may lose their services, which may impair our reputation in the industry and delay the development or commercialization of our approved
424B5
z4tmi8
11 Sep 20
Prospectus supplement for primary offering
4:44pm
424B5
wezh6fbq9ycn2fz0pfek
9 Sep 20
Prospectus supplement for primary offering
4:40pm
424B5
fenhp3
8 Jan 20
Prospectus supplement for primary offering
5:06pm
8-K
EX-99.3
9xg6a2 4bl5qp3e
6 Jan 20
Intra-Cellular Therapies Announces Proposed Public Offering of Common Stock
4:52pm
424B5
azopc2
6 Jan 20
Prospectus supplement for primary offering
4:42pm
S-3ASR
71l9f7 hl7ailo94jj7
6 Jan 20
Automatic shelf registration
4:02pm